http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2021105462-A4
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5a1458017c7f2447cbcc75c39edfa7c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-15 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-40 |
| filingDate | 2021-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9359af45b8fbb69bc0a311f34aec949 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f23d9fcea5780859209c4ab7852b17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b83f542391e722a1e024f9ab777c5cbe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a7066a3dc73a8f54afc510da8b8c119 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e01f3d8d2688579fb3aaa633df87bcaa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_114607c89024a2419e24c4f24083c343 |
| publicationDate | 2021-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2021105462-A4 |
| titleOfInvention | Use of fructus corni nano-powder in resisting type 2 diabetes mellitus |
| abstract | OF THE DISCLOSURE nThe present disclosure provides use of a Fructus Corni nano-powder in resisting type 2 ndiabetes mellitus, and belongs to the technical field of biomedicine. In the present disclosure, nnano pulverization is conducted on Fructus Corni, and the Fructus Corni nano-powder may nbe used to prepare a medicament for treating diabetes mellitus and solve the problems of nsingle hypoglycemic pathway and severe side effects in western medicine, providing a basis nfor lowering the blood glucose through active pharmaceutical ingredients of traditional nChinese medicine. A cornel iridoid glycoside (CIG) of the present disclosure is safer, more neffective, moderate, long-lasting, and free of toxic and side effects; moreover, the nmechanism of action is multiple in effect, target and function, and the efficacy of CIG is of ngreat importance in lowering blood glucose and controlling diabetic complications. nTherefore, the Fructus Corni nano-powder has considerable development and application nvalue in the aspect of diabetes mellitus improvement. nABSTRACT DRAWING - Fig 1 n17970638_1 (GHMatters) P116994.AUn1/4 n16 n14 --- Blank group n- --- High dose group n-A- Middle dose group n-- Low dose group n84 * Model group n-- Positive group n6 n4 n0 50 100 150 200 nTime(min) nFIG.1 |
| priorityDate | 2021-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 272.